SCHEMBL3351656

SCHEMBL3351656

O=C(O)[C@@H](O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834691 1.00
SCHEMBL424600 1.00
SCHEMBL28585483 0.97
SCHEMBL27471698 0.97
SCHEMBL16600582 0.84 TET2 (0.48)
SCHEMBL6054264 0.83 TET2 (0.67)
SCHEMBL3261082 0.83 TET2 (0.67)
SCHEMBL28587073 0.82
SCHEMBL1258360 0.82
SCHEMBL16468883 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110527350-B High-heat-resistance high-crosslinking-degree photocuring solder resist ink and preparation method thereof 鹤山市炎墨科技有限公司 2022-04-15 CN claimed
CN-110527350-A A kind of high heat resistance high-crosslinking-degree photocuring solder mask and preparation method thereof GUANGDONG YANMO TECH CO LTD 2019-12-03 CN claimed
US-6638759-B2 Culturing a racemic acyclic 1,2-diol with a strain belonging to the genus Alcaligenes under aeration; recovering fron the culture broth; purity; simplification DAISO CO., LTD. (JP) 2003-10-28 US claimed
US-20020019034-A1 Process for preparation of optically active 1,2-diols by cultivating microorganisms DAISO CO., LTD. (JP) 2002-02-14 US claimed
EP-1167534-A2 Process for the preparation of optically active 1,2-diols by cultivating microorganisms DAISO CO., LTD. (JP) 2002-01-02 EP claimed
US-20250340912-A1 METHOD FOR PRODUCING 2,4-DIHYDROXY BUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY Technische Universität Dresden (DE) 2025-11-06 US disclosed
CN-115948482-B Construction method and application of 2, 4-dihydroxybutyric acid biosynthesis pathway 中国科学院天津工业生物技术研究所 2024-02-09 CN disclosed
EP-4281572-A1 PROCESS FOR PREPARING 2,4-DIHYDROXYBUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY Technische Universität Dresden (DE) 2023-11-29 EP disclosed
CN-116806263-A Method for producing 2, 4-dihydroxybutyric acid or L-threonine using microbial metabolic pathway 德累斯顿科技大学 2023-09-26 CN disclosed
CN-115948482-A Construction method and application of2, 4-dihydroxybutyric acid biosynthesis pathway 中国科学院天津工业生物技术研究所 2023-04-11 CN disclosed
US-11578029-B2 Method for the production of 2,4-dihydroxybutyric acid DFI USA, LLC (US) 2023-02-14 US disclosed
US-20230019491-A1 PYRIMIDINE TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF EMD Serono Research and Development Institute, Inc. 2023-01-19 US disclosed
US-6638759-B2 Culturing a racemic acyclic 1,2-diol with a strain belonging to the genus Alcaligenes under aeration; recovering fron the culture broth; purity; simplification DAISO CO., LTD. (JP) 2003-10-28 US disclosed
US-6613321-B1 Strain is unable to express homologous O-polysaccharide due to a 1.2 kb deletion that spans the junction of the rfbA and rfbB genes, and expresses a heterologous O-polysaccharide that is covalently linked to a lipopolysaccharide SWISS SERUM AND VACCINE INSTITUTE BERNE (CH) 2003-09-02 US disclosed
US-20020019034-A1 Process for preparation of optically active 1,2-diols by cultivating microorganisms DAISO CO., LTD. (JP) 2002-02-14 US disclosed
EP-1167534-A2 Process for the preparation of optically active 1,2-diols by cultivating microorganisms DAISO CO., LTD. (JP) 2002-01-02 EP disclosed
EP-0854914-A1 LIVE VACCINES AGAINST GRAM-NEGATIVE PATHOGENS, EXPRESSING HETEROLOGOUS O-ANTIGENS Swiss Serum and Vaccine Institute Berne (CH) 1998-07-29 EP disclosed
WO-1997014782-A1 LIVE VACCINES AGAINST GRAM-NEGATIVE PATHOGENS, EXPRESSING HETEROLOGOUS O-ANTIGENS SWISS SERUM AND VACCINE INSTITUTE BERNE (CH) 1997-04-24 WO disclosed
EP-0623026-A1 DETOXIFIED LPS-CHOLERA TOXIN CONJUGATE VACCINE FOR PREVENTION OF CHOLERA THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-11-09 EP disclosed
WO-1993013797-A2 DETOXIFIED LPS-CHOLERA TOXIN CONJUGATE VACCINE FOR PREVENTION OF CHOLERA THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1993-07-22 WO disclosed